Ask AI
ProCE Banner Activity

First Steps in Identifying and Managing Parkinson’s Disease Psychosis

Clinical Thought

An expert provides insights on best practices for identification and management of Parkinson’s disease psychosis.

Released: October 27, 2022

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Acadia Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Marwan Noel Sabbagh, MD, FAAN, FANA

Moreno Family Endowed Chair for Alzheimer’s Research
Director, Applied Alzheimer’s Research Laboratory
Professor of Neurology, Barrow Neurological Institute
Vice Chair for Clinical Research
Creighton University School of Medicine-Phoenix 
Phoenix, Arizona

Marwan Sabbagh, MD, FAAN: consultant/advisor/speaker: Alzheon, Biogen, Eisai, Genentech-Roche, KeifeRx, Lilly, NeuroTherapia, Novo Nordisk, Signant Health, Synaptogenix, T3D; ownership interest (stocks/stock options): Athira, Cortexyme/Quince Therapeutics, NeuroReserve, NeuroTau, Optimal Cognitive Health Company, Seq BioMarque, TransDermix, uMethod Health, Versanum; royalties or patent beneficiary: Humanix.